<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="result">
            <roleset id="result.01" name="" wordnet="2">
                <roles>
                    <role n="0" descr="Theme, prior condition &#x0A;" />
                    <role n="1" descr="Goal, end condition&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, has resulted in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, resulted in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, may result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, may have resulted in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, will result in a Clr phenotype.</text>
                    <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                    <arg n="1">a Clr phenotype</arg>
                </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, can result in a Clr phenotype.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, is able to result in a Clr phenotype.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, is observed to result in a Clr phenotype.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-15 or a lf clr-1 mutation, has the ability to result in a Clr phenotype.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>

              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that has the ability to result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that results in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that has resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that may have resulted in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that can result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              <example src="EGRAM" no="4">
                <text>A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling that is able to result in a Clr phenotype is conferred by either an activated egl-15 or a lf clr-1 mutation.</text>
                <arg n="0">A role for SOS-1 in FGFR-mediated signaling during development Hyperactive EGL-15 FGF receptor signaling</arg>
                <arg n="1">a Clr phenotype</arg>
              </example>
              
                <example src="EGRAM" no="*5">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="*6">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="*8">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="*9">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="*10">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation could have resulted in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
                <example src="EGRAM" no="*11">
                    <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can result in mRNA species with distinct 5UTRs.</text>
                    <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                    <arg n="1">mRNA species with distinct 5UTRs</arg>
                </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are able to result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation are observed to result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have the ability to result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>

              <example src="EGRAM" no="*5">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, have resulted in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*6">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, resulted in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*7">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*8">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, may have resulted in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*9">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, will result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*10">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, could have resulted in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, can result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, are able to result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, are observed to result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              <example src="EGRAM" no="*11">
                <text>Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested, have the ability to result in mRNA species with distinct 5UTRs.</text>
                <arg n="0">Alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as our study suggested,</arg>
                <arg n="1">mRNA species with distinct 5UTRs</arg>
              </example>
              
                <example src="EGRAM" no="*12">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) has resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="*13">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="*15">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) may have resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
                <example src="EGRAM" no="*16">
                    <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) will result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                    <arg n="0">Both the 5 and 3 splice site mutations</arg>
                    <arg n="1">high proportions of mature mRNAs containing introns</arg>
                </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) can result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) are able to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) are observed to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively) have the ability to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*12">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, has resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*13">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*14">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*15">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, may have resulted in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, will result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, can result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, are able to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, are observed to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              <example src="EGRAM" no="*16">
                <text>Both the 5 and 3 splice site mutations (1060 + 2t--&gt;c and 678-7g--&gt;a, respectively), in contrast, have the ability to result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
                <arg n="0">Both the 5 and 3 splice site mutations</arg>
                <arg n="1">high proportions of mature mRNAs containing introns</arg>
              </example>
              
                <example src="EGRAM" no="*17">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that resulted in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="*18">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which has resulted in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
              <example src="EGRAM" no="*18">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 having resulted in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
                <example src="EGRAM" no="*19">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which results in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="*20">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which can result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
                <example src="EGRAM" no="*21">
                    <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 which will result in the substitution of isoleucine for valine.</text>
                    <arg n="0">a new mutation at codon 210</arg>
                    <arg n="1">the substitution of isoleucine for valine</arg>
                </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that may have resulted in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that is able to result in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 being able to result in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that is observed to result in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 being observed to result in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 that has the ability to result in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              <example src="EGRAM" no="*21">
                <text>Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 having the ability to result in the substitution of isoleucine for valine.</text>
                <arg n="0">a new mutation at codon 210</arg>
                <arg n="1">the substitution of isoleucine for valine</arg>
              </example>
              
                <example src="EGRAM" no="22">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, has resulted in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, resulted in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, may have resulted in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, can result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, may result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, is able to result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, is observed to result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                    <arg n="0">Decreased EGL-15 signaling</arg>
                    <arg n="1">a scrawny body morphology phenotype</arg>
                </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling, conferred by a partial lf egl-15 mutation, has the ability to result in a scrawny body morphology phenotype(Kokel et al., 1998).</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>

              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that has the ability to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that is able to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that is observed to result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that results in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that has resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that may have resulted in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that may result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that can result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              <example src="EGRAM" no="28">
                <text>Decreased EGL-15 signaling that will result in a scrawny body morphology phenotype(Kokel et al., 1998) is conferred by a partial lf egl-15 mutation,.</text>
                <arg n="0">Decreased EGL-15 signaling</arg>
                <arg n="1">a scrawny body morphology phenotype</arg>
              </example>
              
                <example src="EGRAM" no="*29">
                    <text>Exon 13 skipping in s1031 animals has resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="*30">
                    <text>Exon 13 skipping in s1031 animals resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="*31">
                    <text>Exon 13 skipping in s1031 animals may have resulted in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="*32">
                    <text>Exon 13 skipping in s1031 animals will result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
                <example src="EGRAM" no="*33">
                    <text>Exon 13 skipping in s1031 animals can result in a 543 bp product.</text>
                    <arg n="0">Exon 13 skipping in s1031 animals</arg>
                    <arg n="1">a 543 bp product</arg>
                </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals is able to result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals is shown to result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals has the ability to result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals has the probability of resulting in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*29">
                <text>Exon 13 skipping in s1031 animals has finally resulted in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*30">
                <text>Exon 13 skipping in s1031 animals finally resulted in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*31">
                <text>Exon 13 skipping in s1031 animals may have finally resulted in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*32">
                <text>Exon 13 skipping in s1031 animals will finally result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals can finally result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals is able to finally result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals is shown to finally result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              <example src="EGRAM" no="*33">
                <text>Exon 13 skipping in s1031 animals has the ability to finally result in a 543 bp product.</text>
                <arg n="0">Exon 13 skipping in s1031 animals</arg>
                <arg n="1">a 543 bp product</arg>
              </example>
              
                <example src="EGRAM" no="*34">
                    <text>Expression of isoform II cDNA in COS7 cells has resulted in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="*35">
                    <text>Expression of isoform II cDNA in COS7 cells result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="*36">
                    <text>Expression of isoform II cDNA in COS7 cells can result in a marked increase in PAF acetylhydrolase activity</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="*37">
                    <text>Expression of isoform II cDNA in COS7 cells may have resulted in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
                <example src="EGRAM" no="*38">
                    <text>Expression of isoform II cDNA in COS7 cells will result in a marked increase in PAF acetylhydrolase activity.</text>
                    <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                    <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
                </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells may result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells are able to result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells are observed to result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells have the ability to result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*34">
                <text>Expression of isoform II cDNA in COS7 cells has finally resulted in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*35">
                <text>Expression of isoform II cDNA in COS7 cells finally result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*36">
                <text>Expression of isoform II cDNA in COS7 cells can finally result in a marked increase in PAF acetylhydrolase activity</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*37">
                <text>Expression of isoform II cDNA in COS7 cells may have finally resulted in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells will finally result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells may finally result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells are able to finally result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells are observed to finally result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              <example src="EGRAM" no="*38">
                <text>Expression of isoform II cDNA in COS7 cells have the ability to finally result in a marked increase in PAF acetylhydrolase activity.</text>
                <arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
                <arg n="1">a marked increase in PAF acetylhydrolase activity</arg>
              </example>
              
                <example src="EGRAM" no="39">
                    <text>Fluctuation in the ras-dependent signaling resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>Fluctuation in the ras-dependent signaling results in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>Fluctuation in the ras-dependent signaling has resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>Fluctuation in the ras-dependent signaling will result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                    <arg n="0">fluctuation in the ras-dependent signaling</arg>
                    <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
                </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling can result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling may result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling may have resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling is able to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling is observed to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling has the ability to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling has the probability of resulting in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="39">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="40">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, results in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="41">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, has resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, will result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, can result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, may result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, may have resulted in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, is able to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, is observed to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, has the ability to result in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              <example src="EGRAM" no="42">
                <text>Fluctuation in the ras-dependent signaling, as we predicted, has the probability of resulting in a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present.</text>
                <arg n="0">fluctuation in the ras-dependent signaling</arg>
                <arg n="1">a dramatic change in vulval induction under the condition where a low level activity of LET-23/SEM-5/SOS-1 is present</arg>
              </example>
              
                <example src="EGRAM" no="43">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
              <example src="EGRAM" no="43">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having resulted in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
                <example src="EGRAM" no="44">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which resulted in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which will result in a super-repeat.</text>
                    <arg n="0">various alternate subdomains</arg>
                    <arg n="1">a super-repeat</arg>
                </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which can result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which may have resulted in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are able to result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being able to result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are observed to result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being observed to result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have the ability to result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having the ability to result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="43">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have completely resulted in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="43">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having completely resulted in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="44">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="45">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which completely resulted in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which will completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which can completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which may have completely resulted in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are able to completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being able to completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which are observed to completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains being observed to completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains which have the ability to completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              <example src="EGRAM" no="46">
                <text>Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains having the ability to completely result in a super-repeat.</text>
                <arg n="0">various alternate subdomains</arg>
                <arg n="1">a super-repeat</arg>
              </example>
              
                <example src="EGRAM" no="*47">
                    <text>Induction of a mutation in the lacI gene has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="*48">
                    <text>Induction of a mutation in the lacI gene resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="*49">
                    <text>Induction of a mutation in the lacI gene results in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
                <example src="EGRAM" no="*50">
                    <text>Induction of a mutation in the lacI gene will result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                    <arg n="0">Induction of a mutation in the lacI gene</arg>
                    <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
                </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene can result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene may result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene could have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene is able to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene is observed to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*47">
                <text>Induction of a mutation in the lacI gene, as our study revealed, has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*48">
                <text>Induction of a mutation in the lacI gene, as our study revealed, resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*49">
                <text>Induction of a mutation in the lacI gene, as our study revealed, results in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, will result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, can result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, may result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, could have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, is able to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              <example src="EGRAM" no="*50">
                <text>Induction of a mutation in the lacI gene, as our study revealed, is observed to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
                <arg n="0">Induction of a mutation in the lacI gene</arg>
                <arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
              </example>
              
                <example src="EGRAM" no="51">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites have resulted in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites resulted in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
              <example src="EGRAM" no="52">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites result in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
                <example src="EGRAM" no="53">
                    <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites will result in simultaneous derepression of both genes.</text>
                    <arg n="0">Mutations</arg>
                    <arg n="0">simultaneous derepression of both genes</arg>
                </example>
              <example src="EGRAM" no="53">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites can result in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites may result in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites may have resulted in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites are able to result in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites are observed to result in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations which prevent repressor binding to either site or alter the phasing of the binding sites have the ability to result in simultaneous derepression of both genes.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="51">
                <text>Mutations that have resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="51">
                <text>Mutations having resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="52">
                <text>Mutations that resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="52">
                <text>Mutations resulting in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="52">
                <text>Mutations that result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that will result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that can result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that may result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that may have resulted in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that are able to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations being able to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that are observed to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations being observed to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
                <text>Mutations that have the ability to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
                <arg n="0">Mutations</arg>
                <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              <example src="EGRAM" no="53">
              <text>Mutations having the ability to result in simultaneous derepression of both genes can prevent repressor binding to either site or alter the phasing of the binding sites.</text>
              <arg n="0">Mutations</arg>
              <arg n="0">simultaneous derepression of both genes</arg>
              </example>
              
                <example src="EGRAM" no="*54">
                    <text>One variant has been found to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="*55">
                    <text>One variant has shown to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="*56">
                    <text>One variant resulted from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="*57">
                    <text>One variant has resulted from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
                <example src="EGRAM" no="*58">
                    <text>One variant was observed to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
              <example src="EGRAM" no="*58">
                    <text>One variant was able to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
              <example src="EGRAM" no="*58">
                    <text>One variant has the ability to result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
              <example src="EGRAM" no="*58">
                    <text>One variant can result from failure to use the normal splice donor site of intron 12.</text>
                    <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                    <arg n="1">One variant</arg>
                </example>
              <example src="EGRAM" no="*54">
                <text>One variant has been found to probably result from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*55">
                <text>One variant has shown to probably result from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*56">
                <text>One variant probably resulted from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*57">
                <text>One variant has probably resulted from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*58">
                <text>One variant was observed to probably result from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*58">
                <text>One variant was able to probably result from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*58">
                <text>One variant has the ability to probably result from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
              <example src="EGRAM" no="*58">
                <text>One variant can probably result from failure to use the normal splice donor site of intron 12.</text>
                <arg n="0">failure to use the normal splice donor site of intron 12</arg>
                <arg n="1">One variant</arg>
              </example>
             
                <example src="EGRAM" no="*59">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="*60">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="*61">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins will result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="*62">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins can resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
                <example src="EGRAM" no="*63">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins may have resulted from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
              <example src="EGRAM" no="*63">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins is able to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
              <example src="EGRAM" no="*63">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins is observed to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
              <example src="EGRAM" no="*63">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has been shown to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
              <example src="EGRAM" no="*63">
                    <text>Sequence analysis of the IDHbeta gene indicates that the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins has the ability to result from alternative splicing of a single transcript.</text>
                    <arg n="0">alternative splicing of a single transcript</arg>
                    <arg n="1">the difference in the C-terminal 28 amino acids between beta(1) and beta(2) proteins</arg>
                </example>
              
                <example src="EGRAM" no="64">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit that has resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="64">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit having resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit that will result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which results in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which can result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which may have resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which is able to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being able to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being observed to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit which has been shown to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="69">
                    <text>The change may cause the heat instability and affect the net charge of the variant subunit being shown to result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                    <arg n="0">the net charge of the variant subunit</arg>
                    <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              <example src="EGRAM" no="64">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit that has finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="64">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit having finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="65">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit that will finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="66">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which finally results in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="67">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="68">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which can finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which may have finally resulted in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which is able to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit being able to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which is observed to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit being observed to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit which has been shown to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
                <example src="EGRAM" no="69">
                  <text>The change may cause the heat instability and affect the net charge of the variant subunit being shown to finally result in an electrophoretic LDH-B subunit variant of the fast type.</text>
                  <arg n="0">the net charge of the variant subunit</arg>
                  <arg n="1">an electrophoretic LDH-B subunit variant of the fast type</arg>
                </example>
              
              
                <example src="EGRAM" no="*70">
                    <text>The research shows the existence of isoforms of NF-YA that results from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*70">
                    <text>The research shows the existence of isoforms of NF-YA resulting from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="*71">
                    <text>The research shows the existence of isoforms of NF-YA which resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*77">
                    <text>We also report the existence of isoforms of NF-YA that will result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="*78">
                    <text>We also reported the existence of isoforms of NF-YA that has resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*78">
                    <text>We also reported the existence of isoforms of NF-YA having resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
                <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA which can result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA that may result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA that may have resulted from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA that is able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA being able to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA that is observed to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA observed to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA that has been shown to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA being shown to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA that has the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              <example src="EGRAM" no="*79">
                    <text>We also reported the existence of isoforms of NF-YA having the ability to result from differential splicing.</text>
                    <arg n="0">differential splicing</arg>
                    <arg n="1">the existence of isoforms of NF-YA</arg>
                </example>
              
                <example src="EGRAM" no="*72">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have resulted in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="*73">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="*74">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) resulted in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="*75">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) may result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) can result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) will result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) may have resulted in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are able to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are observed to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have been shown to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have the ability to result in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
              <example src="EGRAM" no="*76">
                    <text>Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) have the probability of resulting in truncated nonfunctional proteins.</text>
                    <arg n="0">the other three alterations</arg>
                    <arg n="1">truncated nonfunctional proteins</arg>
                </example>
                
                
                <example src="EGRAM" no="81">
                    <text>These observations show that repression is the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>These observations show that repression has been the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>These observations show that repression is believed to be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>                
                <example src="EGRAM" no="85">
                    <text>These observations show that repression may be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>
              <example src="EGRAM" no="85">
                    <text>These observations show that repression is observed to be the result of co-operative binding of the repressor to its two sites, resulting in the formation of a loop of DNA.</text>
                    <arg n="0">co-operative binding of the repressor to its two sites</arg>
                    <arg n="1">repression</arg>
                </example>              
                
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation resulted from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation results from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation has resulted from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation may result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation may have resulted from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation can result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation is able to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation is observed to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation has been shown to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              <example src="EGRAM" no="*80">
                    <text>We show that the negative effect of the cpxA mutation on biofilm formation has the ability to result from a decreased transcription of the curlin encoding csgA gene.</text>
                    <arg n="0">a decreased transcription of the curlin encoding csgA gene</arg>
                    <arg n="1">the negative effect of the cpxA mutation</arg>
                </example>
              
                <example src="EGRAM" no="87">
                    <text>We speculated that this may be the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>We speculated that this is the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
              <example src="EGRAM" no="87">
                    <text>We speculated that this is observed to be the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
            <example src="EGRAM" no="87">
                    <text>We speculated that this has been shown to be the result of the expression of isoforms of Nrf1 in mast cells.</text>
                    <arg n="0">the expression of isoforms of Nrf1</arg>
                    <arg n="1">this</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
